David J. Julius
Chair of Scientific Advisory BoardDr. David J. Julius, Ph.D. serves as Chair of Scientific Advisory Board of Rapport Therapeutics, Inc. from 2026. He serves as Professor for Cellular and Molecular Pharmacology of University of California, San Francisco. He served as a Co-Chair of Scientific Advisory Board at Rapport Therapeutics, Inc until 2026. He serves as a Director of Howard Hughes Medical Institute since 2021. He serves as Vice-Chair in the Department of Cellular and Molecular Pharmacology of University of California, San Francisco. He serves as a Member of Scientific Advisory Board -Ion Channel of Hydra Biosciences, Inc. He serves as a Member of Medical and Scientific Advisory Board at Neurogesx, Inc. He served as a Member of Scientific Advisory Board of Flex Pharma, Inc. He served as a Member of Scientific Advisory Board at Senomyx Inc. In his graduate work, he used genetic and biochemical methods to identify key enzymes involved in the proteolytic maturation of peptide hormones from their polyprotein precursors. He turned his attention to understanding how neurotransmitters, drugs and natural products mediate changes in cell function, physiology and behavior by using a combination of molecular genetic and electrophysiological approaches. A major focus of his laboratory is to probe the molecular mechanisms that underlie nociception and pain. He holds B.S. in life sciences from the Massachusetts Institute of Technology in 1977 and Ph.D. in Biochemistry from the University of California, Berkeley in 1984 and Postdoctoral fellow at the Columbia College of Physicians and Surgeons and Edward S. Harkness Eye Institute.
Positions
- Company NameRapport Therapeutics, Inc.Stock CodeRAPPPositionChair of Scientific Advisory BoardColleagues
- SMSteven M. PaulFounder & Independent Chairman
- ANAbraham N. CeesayCEO, President, Treasurer & Director
- TATroy A. IgnelziChief Financial Officer
- JSJeffrey SevignyChief Medical Officer
- DBDavid BredtFounder & Chief Scientific Officer
- JIJames Irvin HealyIndependent Director
- RJRobert J. PerezIndependent Director
